There is another oral Factor D inhibitor named BCX9930 that is included in ongoing development programs in the treatment of paroxysmal nocturnal hemoglobinuria (ClinicalTrials.gov. This evidence concerns the gene LIF and paroxysmal nocturnal hemoglobinuria.